Search research articles
Contact Us
Filters
Showing results (101-110 of 162) with videos related to
Page
of 17
Sort By:
Journal for Immunotherapy of Cancer
|
June 10, 2022
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
Grace Heloise Attrill, Carina N Owen, Tasnia Ahmed, et al.
The Journal of Pathology
|
October 20, 2011
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro
Belamy B Cheung, Jessica Koach, Owen Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma
Ricardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
Nature Communications
|
April 22, 2020
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H Lee, Elena Shklovskaya, Su Yin Lim, et al.
JCI Insight
|
September 29, 2022
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis
Kazi J Nahar, Felix Marsh-Wakefield, Robert V Rawson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2022
Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
James S Wilmott, Hussein Tawbi, Johnathan A Engh, et al.
Pathology
|
October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes
James S Wilmott, Matthew A Field, Peter A Johansson, et al.
NPJ Precision Oncology
|
January 22, 2026
Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma
Yizhe Mao, Tuba N Gide, Nigel G Maher, et al.
Nature
|
February 12, 2019
Author Correction: Tissue-resident memory CD8<sup>+</sup> T cells promote melanoma-immune equilibrium in skin
Simone L Park, Anthony Buzzai, Jai Rautela, et al.
Nature
|
January 2, 2019
Tissue-resident memory CD8<sup>+</sup> T cells promote melanoma-immune equilibrium in skin
Simone L Park, Anthony Buzzai, Jai Rautela, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 162) with videos related to
Sort By:
Page
of 17
Journal for Immunotherapy of Cancer
|
June 10, 2022
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
Grace Heloise Attrill, Carina N Owen, Tasnia Ahmed, et al.
The Journal of Pathology
|
October 20, 2011
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro
Belamy B Cheung, Jessica Koach, Owen Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma
Ricardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
Nature Communications
|
April 22, 2020
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H Lee, Elena Shklovskaya, Su Yin Lim, et al.
JCI Insight
|
September 29, 2022
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis
Kazi J Nahar, Felix Marsh-Wakefield, Robert V Rawson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2022
Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
James S Wilmott, Hussein Tawbi, Johnathan A Engh, et al.
Pathology
|
October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes
James S Wilmott, Matthew A Field, Peter A Johansson, et al.
NPJ Precision Oncology
|
January 22, 2026
Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma
Yizhe Mao, Tuba N Gide, Nigel G Maher, et al.
Nature
|
February 12, 2019
Author Correction: Tissue-resident memory CD8<sup>+</sup> T cells promote melanoma-immune equilibrium in skin
Simone L Park, Anthony Buzzai, Jai Rautela, et al.
Nature
|
January 2, 2019
Tissue-resident memory CD8<sup>+</sup> T cells promote melanoma-immune equilibrium in skin
Simone L Park, Anthony Buzzai, Jai Rautela, et al.
Page
of 17